S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3

• Mohamad Mohty,
• Michael H. Tomasson,
• Bertrand Arnulf,
• Nizar J Bahlis,
• Paula Rodríguez-Otero,
• Joaquín Martinez-Lopez,
• Cyrille Touzeau,
• Hang Quach,
• Julien Depaus,
• Hisayuki Yokoyama,
• Salomon Manier,
• Noopur Raje,
• Marc S. Raab,
• Emma Searle,
• Eric Leip,
• Sharon T. Sullivan,
• Akos Czibere,
• Andrea Viqueira,
• Alexander Lesokhin

Affiliations

Mohamad Mohty

1 Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France

Michael H. Tomasson

2 Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States

Bertrand Arnulf

3 Hôpital Saint-Louis, Paris, France

Nizar J Bahlis

4 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

Paula Rodríguez-Otero

5 Clinica Universidad de Navarra, Madrid, Spain

Joaquín Martinez-Lopez

6 Hospital Universitario 12 DE OCTUBRE, Madrid, Spain

Cyrille Touzeau

7 University Hospital of Nantes, Nantes, France

Hang Quach

8 University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia

Julien Depaus

9 Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium

Hisayuki Yokoyama

10 Tohoku University Graduate School of Medicine, Sendai, Japan

Salomon Manier

11 Lille University Hospital, Lille, France

Noopur Raje

12 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States

Marc S. Raab

13 Heidelberg Myeloma Center, Department of Hematology/Oncology, Heidelberg University Hospital, Heidelberg, Germany

Emma Searle

14 The Christie Hospital, The University of Manchester, Manchester, United Kingdom

Eric Leip

15 Pfizer, Inc., Cambridge, United States

Sharon T. Sullivan

15 Pfizer, Inc., Cambridge, United States

Akos Czibere

16 Pfizer Inc., New York, United States

Andrea Viqueira

17 Pfizer SLU, Madrid, Spain

Alexander Lesokhin

18 Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States